India to Sri Lanka: Salbutamol Export Trade Route

The India to Sri Lanka Salbutamol corridor is one of India's established pharmaceutical export routes, with 257 shipments documented worth a combined $5.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's salbutamol manufacturing sector.

Across 19 active suppliers, the average shipment value stands at $22.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 20.4%, placing it at rank #6 among India's top salbutamol export destinations globally.

On the import side, key buyers of Indian salbutamol in Sri Lanka include BREATHEFREE LANKA PVT LTD, BREATHEFREE LANKA PVT LTD , BREATHEFREE LANKA PRIVATE LIMITED and 31 others. BREATHEFREE LANKA PVT LTD is the single largest importer with 56 shipments valued at $3.6M USD.

India's salbutamol exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 86 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , ALVITA PHARMA PRIVATE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $22.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as asthalin 400 dp caps (salbutamol sulphat and asthalin inhaler hfa non alcoholic with dose indicator salbutamol sulphate 100 mcg 1x200 md, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BREATHEFREE LANKA PVT LTD is the largest importer with 56 shipments worth $3.6M USD — representing 62% of all salbutamol imports from India on this route. A total of 34 buyers are active on this corridor.